SciELO - Scientific Electronic Library Online

 
vol.65 número3Correlación entre el diagnóstico ecográfico prenatal y posnatal en casos de hidronefrosis fetalNuevos retos en la protección de la vida y salud de las mujeres índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Peruana de Ginecología y Obstetricia

versión On-line ISSN 2304-5132

Resumen

TUTAL MUNOZ, Luis Miguel et al. Pharmacological management of maternal hypertension during breastfeeding: A therapeutic challenge. Rev. peru. ginecol. obstet. [online]. 2019, vol.65, n.3, pp.285-292. ISSN 2304-5132.  http://dx.doi.org/10.31403/rpgo.v66i2183.

Introduction: Hypertensive disorders of pregnancy may persist or appear in the postnatal period, and may require treatment while breastfeeding. There is no current consensus on the pharmacological management of hypertension in this context, and it may represent a challenge for the clinician. Objective: To review the literature on the pharmacological management of maternal hypertension during breastfeeding. Methods: We conducted a literature search on the subject in ScienceDirect, PubMed-Medline, Embase biomedical, SciELO and Cochrane Library, using the terms: "pregnancy induced hypertension AND therapeutics", "postpartum hypertension AND therapeutics", "pregnancy induced hypertension AND treatment", "postpartum hypertension AND treatment". Results: Forty-four relevant articles were considered suitable for this review. Conclusions: The literature reviewed suggests that nifedipine, enalapril, captopril and metoprolol are relatively safe drugs for the breastfeeding infant.

Palabras clave : Preeclampsia; Hypertension; pregnancy-Induced; Therapeutics; Postpartum period; Breastfeeding.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons